The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer

Table 3 Five-year survivals according to risk groups and treatment methods

		LR group	p	IR group	p	HR group	p
		(N = 48)	p	(N = 82)	p	(N = 99)	p
5-y bRFS	EBRT-BT	77%	0.16	73%	0.06	59%	0.1
5-y bRFS	EBRT	88%	0.16	88%	0.06	71%	0.1
5-y RFS	EBRT-BT	94%	0.07	96%	0.03	94%	0.13
5-y RFS	EBRT	100%	0.07	100%	0.03	100%	0.13
5-y MFS	EBRT-BT	100%	0.42	100%	0.15	88%	0.98
5-y MFS	EBRT	96%	0.42	100%	0.15	87%	0.98
5-y OS	EBRT-BT	89%	0.31	88%	0.66	82%	0.72
5-y OS	EBRT	83%	0.31	87%	0.66	85%	0.72

ISSN: 1748-717X